Thursday, June 04, 2020


The World Health Organization (WHO) will resume a clinical trial to study the effects of the anti-malaria drug touted by President Trump as a treatment for COVID-19 after pausing it due to safety concerns, the organization said Wednesday.

Read the rest of the article in The Hill.

No comments: